Pfizer withdraws $125,000 sickle cell treatment Oxbryta worldwide
Pfizer has announced the global withdrawal of its sickle cell disease treatment, Oxbryta (voxelotor), which was priced at approximately $125,000 ...
Pfizer has announced the global withdrawal of its sickle cell disease treatment, Oxbryta (voxelotor), which was priced at approximately $125,000 ...
The Lagos University Teaching Hospital (LUTH), in collaboration with the Sickle Cell Foundation Nigeria (SCFN), has launched a bone marrow ...
ASHIA initiated a program providing free health insurance to children living with sickle cell disorder in with the state ministry ...
The U.S. Food and Drug Administration is set to approve Exa-cel, a potential cure for sickle cell patients, with an ...